BridgeMD

Sign in

Tolerance clinical trials

Explore recruiting tolerance clinical trials.

Recruiting tolerance studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tolerance trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Modular Phase 2a Multicentre Open-Label Study to Investigate DNA-damage Response Agents (or Combinations) in Patients With Advanced Cancer Whose Tumours Contain Molecular Alterations (PLANETTE)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Advanced Respiratory Diseases (INFURO)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

ASPAPY - Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I/II study to determine the safety and efficacy of Ribociclib in combination with hormone therapy and hypofractionated radiotherapy in breast cancer, with positive hormone receptors and negative HER2 status, in newly diagnosed, not immediately operable (or wishing to avoid surgery), elderly patient

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

GAIN-CTNNB1: A Phase I/II open-label trial to evaluate the safety, tolerability, and preliminary efficacy of a single intracerebroventricular administration of an AAV9-based gene replacement therapy in paediatric patients with CTNNB1 syndrome

Slovenia

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

The role of meldonium and individualized physical activities in the treatment of patients with heart failure

Latvia

Therapeutic use (Phase IV) EU CTIS Study details

Tolerance trials by city

Tolerance in Toronto Tolerance in Vancouver Tolerance in Montreal Tolerance in Calgary Tolerance in Edmonton Tolerance in Ottawa Tolerance in Winnipeg Tolerance in Quebec City Tolerance in Hamilton Tolerance in Kitchener Tolerance in London Tolerance in Halifax Tolerance in New York Tolerance in Los Angeles Tolerance in Chicago Tolerance in Houston